JP2017222707A5 - - Google Patents

Download PDF

Info

Publication number
JP2017222707A5
JP2017222707A5 JP2017153348A JP2017153348A JP2017222707A5 JP 2017222707 A5 JP2017222707 A5 JP 2017222707A5 JP 2017153348 A JP2017153348 A JP 2017153348A JP 2017153348 A JP2017153348 A JP 2017153348A JP 2017222707 A5 JP2017222707 A5 JP 2017222707A5
Authority
JP
Japan
Prior art keywords
light
wavelength
less
maximum transmittance
brimonidine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017153348A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017222707A (ja
JP6820812B2 (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2017222707A publication Critical patent/JP2017222707A/ja
Publication of JP2017222707A5 publication Critical patent/JP2017222707A5/ja
Application granted granted Critical
Publication of JP6820812B2 publication Critical patent/JP6820812B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017153348A 2015-12-10 2017-08-08 眼科用医薬製品 Active JP6820812B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2015241390 2015-12-10
JP2015241390 2015-12-10

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2017514571A Division JP6192878B1 (ja) 2015-12-10 2016-12-09 眼科用医薬製品

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2021000497A Division JP7019844B2 (ja) 2015-12-10 2021-01-05 眼科用医薬製品

Publications (3)

Publication Number Publication Date
JP2017222707A JP2017222707A (ja) 2017-12-21
JP2017222707A5 true JP2017222707A5 (enrdf_load_stackoverflow) 2020-01-23
JP6820812B2 JP6820812B2 (ja) 2021-01-27

Family

ID=59013225

Family Applications (6)

Application Number Title Priority Date Filing Date
JP2017514571A Active JP6192878B1 (ja) 2015-12-10 2016-12-09 眼科用医薬製品
JP2017153348A Active JP6820812B2 (ja) 2015-12-10 2017-08-08 眼科用医薬製品
JP2021000497A Active JP7019844B2 (ja) 2015-12-10 2021-01-05 眼科用医薬製品
JP2022014648A Active JP7263579B2 (ja) 2015-12-10 2022-02-02 眼科用医薬製品
JP2023064795A Active JP7494351B2 (ja) 2015-12-10 2023-04-12 眼科用医薬製品
JP2024083625A Pending JP2024098100A (ja) 2015-12-10 2024-05-22 眼科用医薬製品

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2017514571A Active JP6192878B1 (ja) 2015-12-10 2016-12-09 眼科用医薬製品

Family Applications After (4)

Application Number Title Priority Date Filing Date
JP2021000497A Active JP7019844B2 (ja) 2015-12-10 2021-01-05 眼科用医薬製品
JP2022014648A Active JP7263579B2 (ja) 2015-12-10 2022-02-02 眼科用医薬製品
JP2023064795A Active JP7494351B2 (ja) 2015-12-10 2023-04-12 眼科用医薬製品
JP2024083625A Pending JP2024098100A (ja) 2015-12-10 2024-05-22 眼科用医薬製品

Country Status (2)

Country Link
JP (6) JP6192878B1 (enrdf_load_stackoverflow)
WO (1) WO2017099207A1 (enrdf_load_stackoverflow)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR1009419B (el) * 2017-11-07 2018-12-14 Φαρματεν Αβεε Οφθαλμικο φαρμακευτικο σκευασμα που περιεχει εναν συνδυασμο βρινζολαμιδης και βριμονιδινης και μεθοδος για την παρασκευη αυτου
JP2019178083A (ja) * 2018-03-30 2019-10-17 参天製薬株式会社 点眼用水溶液
WO2020071297A1 (ja) * 2018-10-01 2020-04-09 千寿製薬株式会社 水性液剤
JP6798001B1 (ja) * 2019-12-27 2020-12-09 千寿製薬株式会社 医薬製品
JP7728656B2 (ja) * 2020-04-27 2025-08-25 千寿製薬株式会社 ブリモニジンを含有する液体製剤
WO2021220194A1 (en) * 2020-04-29 2021-11-04 Sentiss Pharma Private Limited Ophthalmic compositions comprising a combination of brinzolamide and brimonidine
JP2022063252A (ja) * 2020-10-09 2022-04-21 千寿製薬株式会社 ブリモニジンの液体製剤
WO2022260050A1 (ja) * 2021-06-07 2022-12-15 アイ・セラピーズ・エル・エル・シー ブリモニジンの液体製剤
JP2024097772A (ja) * 2023-01-06 2024-07-19 千寿製薬株式会社 医薬製品

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5153192A (en) * 1990-04-09 1992-10-06 Alcon Laboratories, Inc. Thiophene sulfonamides useful as carbonic anhydrase inhibitors
WO2004073708A1 (en) * 1998-12-17 2004-09-02 Dean Thomas R Brinzolamide and brimonidine for treating ocular conditions
JP2014055028A (ja) * 2012-09-14 2014-03-27 Senju Pharmaceut Co Ltd 光による分解から薬物を保護するためのプラスチック容器
JP6339364B2 (ja) * 2013-12-27 2018-06-06 カズマパートナーズ株式会社 無定形ブリモニジン酒石酸塩及びその製造方法

Similar Documents

Publication Publication Date Title
JP2017222707A5 (enrdf_load_stackoverflow)
CR20170263A (es) Forma cristalina de sulfato acido de (s)-n- (5- ( (r)-2- (2,5-difluorofenil)-pirrolidin-1-il)-pirazolo[1,5-a]-pirimidin-3-il)-3-hidroxipirrolidina-1-carboxamida
CY1122122T1 (el) Υδατικο οφθαλμικο διαλυμα και μεθοδος για τη θεραπευτικη αγωγη συνδρομου ξηρου οφθαλμου
ES2537539T3 (es) Composición oftálmica
EA201691579A1 (ru) Производные сульфамоилпирроламида и их применение в качестве медикаментов для лечения гепатита b
CL2016001918A1 (es) Heteroaril amidas como inhibidores de agregación de proteína
EA201592200A1 (ru) Производные сульфамоилпирроламида и их применение в качестве медикаментов для лечения гепатита b
EA201491771A1 (ru) Офтальмологический раствор, содержащий диквафасол
MX383706B (es) Composiciones de cenicriviroc y métodos para elaborarlas y usarlas.
EA201691881A1 (ru) Новые соединения
EA201791467A1 (ru) Водный офтальмологический раствор
CO2017005544A2 (es) Tableta multicapa que contiene fármaco inestable a la luz
EA201692111A1 (ru) Фармацевтические композиции, содержащие данириксин, для лечения инфекционных заболеваний
UY37498A (es) Una sal maleato de la base libre de n-[5-(aminosulfonil)-4-20 metil-1,3-tiazol-2-il]-n-metil-2-[4-(2-piridinil)-fenil]-acetamida, formulaciones farmacéuticas, métodos de fabricación y usos de la misma
EA201692270A1 (ru) Производные нафтиридиндиона
CY1119520T1 (el) Αλατα 1-(3-μεθυλ-2-οξο-2,3-διυδρο-1,3-βενζοξαζολ-6-υλ)-2,4-διοξο-3-[(1r)-4-(τριφθορομεθυλ)-2,3-διυδρο-1η-ινδενο-1-υλ]-1,2,3,4-τετραϋδροπυριμιδιν-5-καρβοξυλικου οξεος
JP2011063624A5 (enrdf_load_stackoverflow)
EP3569242A4 (en) PHARMACEUTICAL COMPOSITION CONTAINING SULGLYCOTIDE OR A PHARMACEUTICALLY ACCEPTABLE SALT OF SUCH FOR THE PURPOSE OF PREVENTION OR TREATMENT OF DRY EYE
EA201691878A1 (ru) ИНГИБИТОРЫ СИГНАЛЬНЫХ ПУТЕЙ Wnt
CL2017002900A1 (es) Autenticación de envasado
AR108235A1 (es) Formas de dosificación oral de magnesio de liberación controlada, de alta carga y métodos para elaborar y utilizar las mismas
JP2013082696A5 (enrdf_load_stackoverflow)
EA201890122A1 (ru) Применение 2-(5s-метил-2-оксо-4r-фенилпирролидин-1-ил)ацетамида в лечении судорог
JP2022155560A5 (enrdf_load_stackoverflow)
RU2015131414A (ru) Коллоидный раствор наносеребра в этиленгликоле и способ его получения